Stock TEVA TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE

Equities

TEVA

IL0006290147

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 10:24:19 2024-05-09 am EDT 		5-day change 1st Jan Change
5,870 ILa +0.95% Intraday chart for Teva Pharmaceutical Industries Limited +13.45% +53.87%
May. 08 Sector Update: Health Care Stocks Slipping Wednesday Afternoon MT
May. 08 Teva Pharmaceutical Shares Rise After Reporting Higher Q1 Earnings, Revenue; 2024 Guidance Reaffirmed MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-749 as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia
AQ
Teva Pharmaceutical Industries : Immediate Report
PU
Sector Update: Health Care Stocks Slipping Wednesday Afternoon
MT
Teva Pharmaceutical Shares Rise After Reporting Higher Q1 Earnings, Revenue; 2024 Guidance Reaffirmed
MT
Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday
MT
Sector Update: Health Care
MT
Teva Pharmaceutical Industries Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed
MT
Earnings Flash (TEVA) TEVA PHARMACEUTICAL INDUSTRIES LIMITED Posts Q1 Revenue $3.82B
MT
Earnings Flash (TEVA) TEVA PHARMACEUTICAL INDUSTRIES LIMITED Posts Q1 EPS $0.48
MT
Transcript : Teva Pharmaceutical Industries Limited, Q1 2024 Earnings Call, May 08, 2024
Teva Pharm Q1 profit falls short of estimates, revenue gains
RE
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
BU
Teva Pharmaceutical Industries Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Teva Pharmaceutical Industries Limited Reports Impairment of Long-Lived Assets for the Three Months Ended March 31, 2024
CI
Teva Pharmaceutical Industries Limited Reaffirms Earnings Guidance for the Full Year 2024
CI
Teva's 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets
AQ
Teva to Present at the 2024 Bank of America Healthcare Conference
BU
Teva’s 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets
BU
Alvotech - U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-FreeInterchangeable Biosimilar to Humira
AQ
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TEVA Stock
  4. TEVA Stock
  5. News Teva Pharmaceutical Industries Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW